Latest Stock Market News

Hindustan Aeronautics Limited (HAL) stock is off its 52-week high of Rs 2,914 and may test this level again riding on current momentum. The stock is expected to gain up to Rs 674 per share, returning nearly 26% returns on the current market price. A host of technical and fundamental triggers could lead the uptick.

β€œOn the weekly chart, the stock has given a breakout from a symmetrical triangle which is a bullish continuation sign. Stock is sailing above short to long term moving average across all the time frame, it echoes positive tone in short to long term time frame,” added Shah.

ICICI Pru Life shares drop 0.05% as Sensex falls

Updated at : 2023-03-28 13:05:03

Rate this item

(1 Vote)

The stock quoted a 52-week high of Rs 608.65 and a 52-week low of Rs 380.95.

Rate this item

(1 Vote)

As of 31-Dec-2022, promoters held 41.94 per cent stake in the company, while FIIs held 26.77 per cent and domestic institutional investors had 14.49 per cent.

Trent among 6 stocks that closed above their 200 DMA

Updated at : 2023-03-28 13:05:03

Rate this item

(1 Vote)

In the NSE list of stocks with a market cap of over Rs 1000 crore, six stocks closed above their 200 DMA (Daily Moving Averages) on March 27.

Amara Raja Batteries, incorporated in the year 1985, is a Mid Cap company (having a market cap of Rs 9576.60 Crore) operating in Auto Ancillaries sector.

GAIL shares up 0.43% as Nifty drops

Updated at : 2023-03-28 13:05:03

Rate this item

(1 Vote)

A total of 171,165 shares changed hands on the counter till 11:33AM (IST).

Rate this item

(1 Vote)

In the domestic equity market, the 30-share BSE Sensex advanced 220.99 points or 0.38 per cent to 57,748.09 points. The broader NSE Nifty gained 76.10 points or 0.45 per cent to 17,021.15 points. Foreign Institutional Investors (FIIs) were net sellers in the capital market on Friday as they offloaded shares worth Rs 1,720.44 crore, according to exchange data.

Rate this item

(1 Vote)

Shares of Lupin ended 3.3% higher after the company received tentative approval from USFDA for Valbenazine Capsules. Investors lost Rs 1.12 lakh crore on Monday

Rate this item

(1 Vote)

Dabur India key Products/Revenue Segments include Personal Care, Other Operating Revenue and Scrap for the year ending 31-Mar-2022.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.